IP Library › Assignment 056414/0241
Patent Assignment
Reel/Frame 056414/0241

Assignment of Assignor's Interest

Recorded: 2021-06-02 Pages: 14
Assignor
MOLECULAR TEMPLATES, INC.
Executed: 2020-12-08
Assignee
IMMUNOGENESIS, INC.
2450 HOLCOMBE BLVD, SUITE J, HOUSTON, TEXAS, 77021
Covered Properties (27)
Compositions and Methods for Treating Cancer
Phosphoramidate Alkylator Prodrugs
Phosphoramidate Alkylator Prodrugs for the Treatment of Cancer
Treatment of Cancer Using Hypoxia Activated Prodrugs
Administration of Hypoxia Activated Prodrugs and Antiangiogenic Agents for the Treatment of Cancer
Methods for Treating Cancer
Treatment of Cancer
Predictive Biomarker for Hypoxia-Activated Prodrug Therapy
Th-302 Solid Forms and Methods Related Thereto
Predictive Biomarker for Hypoxia-Activated Prodrug Therapy
Aziridine Containing Dna Alkylating Agents
Administration of Hypoxia Activated Prodrugs in Combination with Immune Modulatory Agents for Treating Cancer
Compositions and Methods for Treating Cancer
Patent: 7,550,496 →
Application: 10/549,545 →
Publication: US 2006/0258656
Phosphoramidate Alkylator Prodrugs
Patent: 8,003,625 →
Application: 11/993,822 →
Publication: US 2010/0137254
Compositions and Methods for Treating Cancer
Patent: 8,299,088 →
Application: 12/484,104 →
Publication: US 2009/0312276
Phosphoramidate Alkylator Prodrugs for the Treatment of Cancer
Patent: 8,552,048 →
Application: 12/521,290 →
Publication: US 2010/0183742
Treatment of Cancer Using Hypoxia Activated Prodrugs
Patent: 8,946,275 →
Application: 13/125,303 →
Publication: US 2013/0202716
Phosphoramidate Alkylator Prodrugs
Patent: 8,507,464 →
Application: 13/163,303 →
Publication: US 2011/0251159
Phosphoramidate Alkylator Prodrugs
Patent: 8,664,204 →
Application: 13/941,261 →
Publication: US 2013/0303778
Phosphoramidate Alkylator Prodrugs
Patent: 9,226,932 →
Application: 14/102,213 →
Publication: US 2014/0170240
Predictive Biomarker for Hypoxia-Activated Prodrug Therapy
Application: 15/035,131 →
Publication: US 2016/0250236
Th-302 Solid Forms and Methods Related Thereto
Application: 15/326,990 →
Publication: US 2017/0210769
Predictive Biomarker for Hypoxia-Activated Prodrug Therapy
Application: 15/528,067 →
Publication: US 2018/0334716
Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
Application: 15/998,702 →
Publication: US 2019/0060275
Th-302 Solid Forms and Methods Related Thereto
Application: 16/193,160 →
Publication: US 2019/0127404
Administration of Hypoxia Activated Prodrugs in Combination with Immune Modulatory Agents for Treating Cancer
Application: 16/322,467 →
Publication: US 2021/0369746
Aziridine Containing Dna Alkylating Agents
Application: 16/392,477 →
Publication: US 2020/0085786
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 30, 2004
From: MATTEUCCI, MARK; RAO, PHOTON; DUAN, JIAN-XIN
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 014586/0159 →
Assignment of Assignor's Interest Jan 30, 2006
From: MATTEUCCI, MARK; RAO, PHOTON; DUAN, JIAN-XIN
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 017117/0838 →
Assignment of Assignor's Interest May 14, 2008
From: MATTEUCCI, MARK; DUAN, JIAN-XIN; JIAO, HAILONG; KAIZERMAN, JACOB
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 020992/0197 →
Assignment of Assignor's Interest Aug 13, 2009
From: MATTEUCCI, MARK; DUAN, JIAN-XIN; JIAO, HAILONG; KAIZERMAN, JACOB
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 023098/0519 →
Corrective Assignment to Correct the Remove Inventor Steve Ammons Previously Recorded on Reel 020992 Frame 0197. Assignor(S) Hereby Confirms the Assignment. Aug 28, 2009
From: MATTEUCCI, MARK; DUAN, JIAN-XIN; JIAO, HAILONG; KAIZERMAN, JACOB
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 023165/0722 →
Assignment of Assignor's Interest Apr 16, 2010
From: AMMONS, STEVE; DUAN, JIAN-XIN; JUNG, DONALD; MATTEUCCI, MARK
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 024246/0058 →
Assignment of Assignor's Interest Nov 23, 2010
From: CURD, JOHN G.; KROLL, STEWART; MATTEUCCI, MARK; HART, CHARLES P.
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 025401/0046 →
Assignment of Assignor's Interest Jul 2, 2012
From: MATTEUCCI, MARK; RAO, PHOTON; DUAN, JIAN-XIN
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 028480/0065 →
Assignment of Assignor's Interest Sep 19, 2013
From: HART, CHARLES; CURD, JOHN; KROLL, STEWART; SUN, JESSICA
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 031244/0476 →
Assignment of Assignor's Interest Sep 19, 2013
From: HART, CHARLES; MATTEUCCI, MARK; CURD, JOHN
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 031244/0425 →
Assignment of Assignor's Interest May 26, 2015
From: SUN, JESSICA D.
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 035709/0964 →
Assignment of Assignor's Interest May 26, 2015
From: SUN, JESSICA D.
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 035710/0116 →
Assignment of Assignor's Interest Nov 4, 2015
From: MATTEUCCI, MARK; DUAN, JIAN-XIN; JIAO, HAILONG
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 036958/0762 →
Security Agreement Feb 28, 2018
From: MOLECULAR TEMPLATES OPCO, INC.; MOLECULAR TEMPLATES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 045466/0472 →
Assignment of Assignor's Interest Apr 5, 2018
From: DUAN, JIAN-XIN; MATTEUCCI, MARK; DAVAR, NIPUN; ANDERSEN, DENISE
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 045452/0518 →
Change of Name Apr 5, 2018
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 045848/0843 →
Assignment of Assignor's Interest Apr 16, 2018
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 045953/0044 →
Assignment of Assignor's Interest Aug 1, 2018
From: MERCK PATENT GMBH
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 046529/0890 →
Assignment of Assignor's Interest Aug 1, 2018
From: ELENBAAS, BRIAN A.; SHEN, LEI
To: MERCK PATENT GMBH
Reel/Frame 046529/0855 →
Change of Name and Address Oct 12, 2018
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 048404/0347 →
Assignment of Assignor's Interest Feb 8, 2019
From: MERCK PATENT GMBH
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 048275/0953 →
Change of Name May 7, 2020
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 052607/0818 →
Release of Security Interest May 22, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: MOLECULAR TEMPLATES OPCO, INC.
Reel/Frame 052733/0890 →
Assignment of Assignor's Interest Jul 23, 2020
From: ELENBAAS, BRIAN A.; GUALBERTO, ANTONIO; HART, CHARLES PRARAY
To: MERCK PATENT GMBH; MOLECULAR TEMPLATES, INC.
Reel/Frame 053298/0306 →
Change of Name Jul 23, 2020
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 053304/0710 →